Market Value2,003,435,000
Total Holdings57
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GERN / Geron Corporation
ALLK / Allakos Inc.
CTIC / CTI BioPharma Corp
US0846561076 / Berkshire Grey, Inc.
LUMO / Lumos Pharma, Inc.
MILE / Metromile Inc
GLBE / Global-E Online Ltd.
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
VTGN / Vistagen Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
TUYA / Tuya Inc. - Depositary Receipt (Common Stock)
SVRA / Savara Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ZFOX / ZeroFox Holdings, Inc.
AKUS / Akouos Inc
MEIP / MEI Pharma, Inc.
BHG / Bright Health Group, Inc.
EAR / Eargo, Inc.
UP / Wheels Up Experience Inc.
NOTE / FiscalNote Holdings, Inc.
PANW / Palo Alto Networks, Inc.
OYST / Oyster Point Pharma Inc
BILL / BILL Holdings, Inc.
ACLX / Arcellx, Inc.
CRSP / CRISPR Therapeutics AG
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
AUPH / Aurinia Pharmaceuticals Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
NET / Cloudflare, Inc.
OBSV / ObsEva SA.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
PHAS / PhaseBio Pharmaceuticals Inc
MIMO / Airspan Networks Holdings Inc.
BZFD / BuzzFeed, Inc.
SYBX / Synlogic, Inc.
DMYI.U / dMY Technology Group, Inc. III Units, each consisting of one share of Class A common stock and one-f
STSA / Satsuma Pharmaceuticals Inc
TCON / TRACON Pharmaceuticals, Inc.
MRKR / Marker Therapeutics, Inc.
AFMD / Affimed N.V.
NKTX / Nkarta, Inc.
AVEO / AVEO Pharmaceuticals Inc
ADXN / Addex Therapeutics Ltd - Depositary Receipt (Common Stock)
SNTI / Senti Biosciences, Inc.
GLYC / GlycoMimetics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
XERS / Xeris Biopharma Holdings, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
NN / NextNav Inc.
INZY / Inozyme Pharma, Inc.
TRVI / Trevi Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
UTRS / Minerva Surgical, Inc.
XFOR / X4 Pharmaceuticals, Inc.
CSBR / Champions Oncology, Inc.
RGLS / Regulus Therapeutics Inc.
COUR / Coursera, Inc.
CVRX / CVRx, Inc.
DM / Desktop Metal, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
RPHM / Reneo Pharmaceuticals, Inc.